サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1412855

ルシフェラーゼアッセイ市場：測定法別、用途別-2024-2030年世界予測

Luciferase Assays Market by Method (Dual Reporter Assay, Flash Assay, Glow Assay), Application (Gene Expression, metabolic Activity, protein-Protein Interaction) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ルシフェラーゼアッセイ市場：測定法別、用途別-2024-2030年世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ルシフェラーゼアッセイ市場規模は2023年に15億米ドルと推計され、2024年には16億米ドルに達し、CAGR 7.03%で2030年には24億2,000万米ドルに達すると予測されます。

ルシフェラーゼアッセイの世界市場

主な市場の統計
基準年[2023］ 15億米ドル
予測年[2024］ 16億米ドル
予測年 [2030] 24億2,000万米ドル
CAGR（%） 7.03%
ルシフェラーゼアッセイ Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはルシフェラーゼアッセイ市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、ルシフェラーゼアッセイ市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-ルシフェラーゼアッセイ市場の市場規模および予測は？

2-ルシフェラーゼアッセイ市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-ルシフェラーゼアッセイ市場における技術動向と規制の枠組みは？

4-ルシフェラーゼアッセイ市場における主要ベンダーの市場シェアは？

5-ルシフェラーゼアッセイ市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 分子生物学と遺伝子工学における応用の増加
      • 遺伝子発現をリアルタイムに定量的に可視化する技術開発
      • 調査と政府支援への投資の拡大
    • 抑制要因
      • 発光を発生させるには分子状酸素の必要性
    • 機会
      • 飲料業界で微生物汚染をチェックする用途が増加
      • プレイヤー間の戦略的協力
    • 課題
      • 関連する技術的な問題
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 ルシフェラーゼアッセイ市場：方法別

  • デュアルレポーターアッセイ
  • フラッシュアッセイ
  • グローアッセイ
  • シングルレポーターアッセイ

第7章 ルシフェラーゼアッセイ市場：用途別

  • 遺伝子発現
  • 代謝活動
  • プレオテインとタンパク質の相互作用
  • 翻訳後の修正

第8章 南北アメリカのルシフェラーゼアッセイ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のルシフェラーゼアッセイ市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのルシフェラーゼアッセイ市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • AAT Bioquest, Inc.
    • Abcam PLC
    • Active Motif, Inc.
    • Biotium
    • GeneCopoeia, Inc.
    • Gold Biotechnology
    • Invivogen
    • Lonza Group AG
    • Merck KGaA
    • Molecular Devices, LLC
    • Novus Biologicals
    • OriGene Technologies, Inc.
    • OZ Biosciences
    • Perkin Elmer, Inc.
    • Promega Corporation
    • PromoCell GmbH
    • SwitchGear Genomics, Inc.
    • Takara Bio Inc.
    • Thermo Fisher Scientific, Inc.
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. LUCIFERASE ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. LUCIFERASE ASSAYS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. LUCIFERASE ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. LUCIFERASE ASSAYS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. LUCIFERASE ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. LUCIFERASE ASSAYS MARKET DYNAMICS
  • FIGURE 7. LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 8. LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. LUCIFERASE ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. LUCIFERASE ASSAYS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. LUCIFERASE ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. LUCIFERASE ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 6. LUCIFERASE ASSAYS MARKET SIZE, BY DUAL REPORTER ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. LUCIFERASE ASSAYS MARKET SIZE, BY FLASH ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. LUCIFERASE ASSAYS MARKET SIZE, BY GLOW ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. LUCIFERASE ASSAYS MARKET SIZE, BY SINGLE REPORTER ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. LUCIFERASE ASSAYS MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. LUCIFERASE ASSAYS MARKET SIZE, BY METABOLIC ACTIVITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. LUCIFERASE ASSAYS MARKET SIZE, BY PREOTEIN-PROTEIN INTERACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. LUCIFERASE ASSAYS MARKET SIZE, BY POST-TRANSLATION MODIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. LUCIFERASE ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 102. LUCIFERASE ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. LUCIFERASE ASSAYS MARKET LICENSE & PRICING
目次
Product Code: MRR-0302D35AB54C

[193 Pages Report] The Luciferase Assays Market size was estimated at USD 1.50 billion in 2023 and expected to reach USD 1.60 billion in 2024, at a CAGR 7.03% to reach USD 2.42 billion by 2030.

Global Luciferase Assays Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.50 billion
Estimated Year [2024] USD 1.60 billion
Forecast Year [2030] USD 2.42 billion
CAGR (%) 7.03%
Luciferase Assays Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Luciferase Assays Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Luciferase Assays Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Luciferase Assays Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Abcam PLC, Active Motif, Inc., Biotium, GeneCopoeia, Inc., Gold Biotechnology, Invivogen, Lonza Group AG, Merck KGaA, Molecular Devices, LLC, Novus Biologicals, OriGene Technologies, Inc., OZ Biosciences, Perkin Elmer, Inc., Promega Corporation, PromoCell GmbH, SwitchGear Genomics, Inc., Takara Bio Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Luciferase Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Method
    • Dual Reporter Assay
    • Flash Assay
    • Glow Assay
    • Single Reporter Assay
  • Application
    • Gene Expression
    • Metabolic Activity
    • Preotein-Protein Interaction
    • Post-Translation Modification
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Luciferase Assays Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Luciferase Assays Market?

3. What are the technology trends and regulatory frameworks in the Luciferase Assays Market?

4. What is the market share of the leading vendors in the Luciferase Assays Market?

5. Which modes and strategic moves are suitable for entering the Luciferase Assays Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Luciferase Assays Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased application in molecular biology and genetic engineering
      • 5.1.1.2. Technological development to permit the quantitative visualization of gene expression in real time
      • 5.1.1.3. Growing investment in research and government support
    • 5.1.2. Restraints
      • 5.1.2.1. Necessity for molecular oxygen to generate luminescence
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing uses in beverage industry to check microbial contamination
      • 5.1.3.2. Strategic collaboration between players
    • 5.1.4. Challenges
      • 5.1.4.1. Associated technical issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Luciferase Assays Market, by Method

  • 6.1. Introduction
  • 6.2. Dual Reporter Assay
  • 6.3. Flash Assay
  • 6.4. Glow Assay
  • 6.5. Single Reporter Assay

7. Luciferase Assays Market, by Application

  • 7.1. Introduction
  • 7.2. Gene Expression
  • 7.3. Metabolic Activity
  • 7.4. Preotein-Protein Interaction
  • 7.5. Post-Translation Modification

8. Americas Luciferase Assays Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Luciferase Assays Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Luciferase Assays Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. AAT Bioquest, Inc.
    • 12.1.2. Abcam PLC
    • 12.1.3. Active Motif, Inc.
    • 12.1.4. Biotium
    • 12.1.5. GeneCopoeia, Inc.
    • 12.1.6. Gold Biotechnology
    • 12.1.7. Invivogen
    • 12.1.8. Lonza Group AG
    • 12.1.9. Merck KGaA
    • 12.1.10. Molecular Devices, LLC
    • 12.1.11. Novus Biologicals
    • 12.1.12. OriGene Technologies, Inc.
    • 12.1.13. OZ Biosciences
    • 12.1.14. Perkin Elmer, Inc.
    • 12.1.15. Promega Corporation
    • 12.1.16. PromoCell GmbH
    • 12.1.17. SwitchGear Genomics, Inc.
    • 12.1.18. Takara Bio Inc.
    • 12.1.19. Thermo Fisher Scientific, Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing